Letter From The Editor

As a diabetes educator and pharmacist, I have had a lot of success helping patients improve their diabetes care. But at the end of the day, I get to go home diabetes free. This week, one of my pals and a pharmacist educator is sharing his professional and personal opinions …

We’re excited to announce the relaunch of the DiabetesInControl.com website! The new site features the same great content in a fresh design optimized to deliver great user experience. Please note: some of our most popular content, “Tools for Your Practice,” is now subscriber-exclusive to reward our loyal readers. In order to access this content, …

We’re excited to let you know that on October 1st, 2015, we will be relaunching DiabetesInControl.com. The refreshed site will feature a clean, new look and feel, with enhanced navigation to make it even easier to find all our great content. We’ve also decided to make some of our most …

Reminder – on October 1st, 2015, we will be relaunching DiabetesInControl.com. The refreshed site will feature a clean, new look and feel, with enhanced navigation to make it even easier to find all our great content. We’ve also decided to make some of our most popular content, including our “Tools …

It seems like every time we get good news about a diabetes drug, the bad has to surface. This week, Lilly and BI announced some great heart results with their drug Jardiance, while the FDA tightened up its warning on Invokana and fracture risk. The same thing happens in other …

I was reading this week’s Clinical Gem about the use of diuretics for reducing heart failure and blood pressure values. There was a mention of the differences in responses among certain ethnic groups and the difficulty that we often have with African-American patients. There was a lot of focus on …

GLP-1 analog therapy hit a new threshold last month with the most prescriptions ever filled in a 30-day period. There are also more prescribers using these products than ever before. I think that one of the reasons is the fear of needles has decreased. I believe that it was not …

The diabetes newsletters and services have all been carrying articles about the artificial pancreas. There are three basic components to the device. There is a pump to deliver insulin and a pump to deliver glucagon, however, the “brains” of the system is the glucose reading device. Without the brains, then …

DPP4-Inhibitors have been on the market for seven years and, in that time, over 1 million patients have used the drug. Out of those patients, 33 reported severe joint pain. Now the FDA has published a warning, which will possibly cause prescribers and patients to discontinue using the drug. Although …

While researching some information for a CE I was preparing, I found out that approximately 74% of patients with diabetes have mild to severe hypertension. This means that in addition to the possible kidney damage caused by diabetes, most or our patients are also at risk for more kidney damage …